Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: RCT of Psilocybin-assisted CBT for Depression [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 randomized trial is evaluating psilocybin-assisted cognitive behavioral therapy for major depressive disorder; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Major Depressive Diorder | Phase 1, Phase 2 | Status: RECRUITING